News

We are updating the Brighton website and need help from frequent users to advance requirements and provide design feedback. We will do this work[...]

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Brighton Collaboration, based in Atlanta at The Task Force for Global Health, announced the expansion of[...]

SPEAC has completed a fifth update to the Priority List of potential Adverse events of special interest relevant to COVID-19 vaccine trials.  Past[...]

We are proud to announce that Dr. Bob Chen, Scientific Director of the Brighton Collaboration, received a special award for “Contributions to Public Health[...]

To help meet its increasing needs, the Secretariat for the Brighton Collaboration (BC) has recently posted a new staff position: Director of Research. The position[...]

Coalition for Epidemic Preparedness Innovations (CEPI) through the Safety Platform for Emergency vACcines (SPEAC) project, has funded the development of a training program for potential[...]

On behalf of the COVAX Vaccine Safety Working group: After COVID-19 vaccines are introduced into countries, it will be vital to generate real-world[...]

The current Brighton Collaboration Science Board has voted to accept all 16 candidates onto the new Brighton Collaboration Science Board. After consideration of[...]

SPEAC has completed a 4th update of the COVID-19 clinical literature covering the period from November 2020 – August 2021. Click HERE to[...]

We would like to announce the upcoming Brighton Collaboration Science Board election. The Science Board meets monthly for one hour to help determine[...]

As part of its role to support the assessment of safety of vaccines being evaluated in CEPI funded clinical trials, the Safety Platform[...]

Recent news of the possible complications of blood clots – or Thrombosis with Thrombocytopenia Syndrome (TTS) – following the AstraZeneca/Oxford and Johnson &[...]